4/20
12:44 pm
ktta
Pasithea Therapeutics (KTTA) had its "buy" rating reaffirmed by HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
Pasithea Therapeutics (KTTA) had its "buy" rating reaffirmed by HC Wainwright. They now have a $3.00 price target on the stock.